C. Rossetto

410 total citations
16 papers, 136 citations indexed

About

C. Rossetto is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, C. Rossetto has authored 16 papers receiving a total of 136 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in C. Rossetto's work include Lung Cancer Treatments and Mutations (12 papers), Lung Cancer Diagnosis and Treatment (6 papers) and Lung Cancer Research Studies (5 papers). C. Rossetto is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Lung Cancer Diagnosis and Treatment (6 papers) and Lung Cancer Research Studies (5 papers). C. Rossetto collaborates with scholars based in Italy, United Kingdom and United States. C. Rossetto's co-authors include Daris Ferrari, M. Guaraldi, Maria Grazia Ghi, H. Koussis, Andrea Bonetti, Gianpiero Fasola, Consuelo D'Ambrosio, Adriano Paccagnella, Paolo Foa and Giuseppe Azzarello and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

C. Rossetto

14 papers receiving 132 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Rossetto Italy	6	78	72	70	52	30	16	136
Wei-Han Hu China	4	85 1.1×	46 0.6×	53 0.8×	49 0.9×	14 0.5×	6	118
Shaoqiang Liang China	5	73 0.9×	31 0.4×	35 0.5×	38 0.7×	20 0.7×	10	111
Xuping Xi China	5	59 0.8×	37 0.5×	30 0.4×	16 0.3×	26 0.9×	9	96
Kwok Hung Au China	4	43 0.6×	46 0.6×	45 0.6×	23 0.4×	12 0.4×	7	87
Michaela K. Keck United States	6	59 0.8×	43 0.6×	54 0.8×	18 0.3×	32 1.1×	13	106
Behzad Bidadi United States	5	50 0.6×	42 0.6×	62 0.9×	22 0.4×	15 0.5×	23	96
Qing-Nan Tang China	8	111 1.4×	52 0.7×	66 0.9×	62 1.2×	7 0.2×	9	136
Xinglai Feng China	7	54 0.7×	20 0.3×	59 0.8×	35 0.7×	8 0.3×	12	102
Crosby D. Rock United States	6	49 0.6×	38 0.5×	43 0.6×	23 0.4×	45 1.5×	11	145
Sanchit Trivedi United States	4	34 0.4×	24 0.3×	58 0.8×	49 0.9×	28 0.9×	9	102

Countries citing papers authored by C. Rossetto

Since Specialization

Citations

This map shows the geographic impact of C. Rossetto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Rossetto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Rossetto more than expected).

Fields of papers citing papers by C. Rossetto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Rossetto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Rossetto. The network helps show where C. Rossetto may publish in the future.

Co-authorship network of co-authors of C. Rossetto

This figure shows the co-authorship network connecting the top 25 collaborators of C. Rossetto. A scholar is included among the top collaborators of C. Rossetto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Rossetto. C. Rossetto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Rossetto, C., et al.. (2025). Utility of the radiological report function of an artificial intelligence system in interpreting CBCT images: a technical report. Dentomaxillofacial Radiology. 54(3). 239–244. 2 indexed citations

Costa, José Luís, Alexandro Membrino, Simona Rizzato, et al.. (2024). The Role of ctDNA in the Management of Non-Small-Cell Lung Cancer in the AI and NGS Era. International Journal of Molecular Sciences. 25(24). 13669–13669. 4 indexed citations

Pelizzari, Giacomo, Carla Corvaja, Giada Targato, et al.. (2021). 1312P Prognostic impact of KRAS status in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitor monotherapy. Annals of Oncology. 32. S1011–S1011. 1 indexed citations

Pelizzari, Giacomo, Francesco Cortiula, Michele Bartoletti, et al.. (2020). Platinum-Based Chemotherapy in Older Patients with Non-Small Cell Lung Cancer: What to Expect in the Real World. Drugs & Aging. 37(9). 677–689. 2 indexed citations

Fasola, Gianpiero, Ornella Belvedere, Fabio Barbone, et al.. (2017). P1.03-035 Does Screening with Low-Dose Computed Tomography (LDCT) of Asbestos Exposed Subjects Reduce Mortality for Lung Cancer (LC)?. Journal of Thoracic Oncology. 12(1). S563–S564. 1 indexed citations

Paccagnella, Adriano, Daris Ferrari, P. Foa, et al.. (2015). OC-006: Concomitant treatment (CRT or cetuximab/RT) with or without induction TPF in Locally Advanced head and neck. Radiotherapy and Oncology. 114. 8–9. 2 indexed citations

Ghi, Maria Grazia, Adriano Paccagnella, Daris Ferrari, et al.. (2014). Concomitant chemoradiation (CRT) or cetuximab/RT (CET/RT) versus induction Docetaxel/ Cisplatin/5-Fluorouracil (TPF) followed by CRT or CET/RT in patients with Locally Advanced Squamous Cell Carcinoma of Head and Neck (LASCCHN). A randomized phase III factorial study (NCT01086826).. Journal of Clinical Oncology. 32(15_suppl). 6004–6004. 48 indexed citations

Ghi, Maria Grazia, Adriano Paccagnella, Daris Ferrari, et al.. (2013). A phase II-III study comparing concomitant chemoradiotherapy (CRT) versus cetuximab/RT (CET/RT) with or without induction docetaxel/cisplatin/5-fluorouracil (TPF) in locally advanced head and neck squamous cell carcinoma (LASCCHN): Efficacy results (NCT01086826).. Journal of Clinical Oncology. 31(15_suppl). 6003–6003. 20 indexed citations

Ghi, Maria Grazia, Adriano Paccagnella, Daris Ferrari, et al.. (2012). Cetuximab/radiotherapy (CET+RT) versus concomitant chemoradiotherapy (cCHT+RT) with or without induction docetaxel/cisplatin/5-fluorouracil (TPF) in locally advanced head and neck squamous cell carcinoma (LASCCHN): Preliminary results on toxicity of a randomized, 2x2 factorial, phase II-III study (NCT01086826).. Journal of Clinical Oncology. 30(15_suppl). 5513–5513. 11 indexed citations

10.

Belvedere, Ornella, Alessandro Follador, C. Rossetto, et al.. (2011). A randomised phase II study of docetaxel/oxaliplatin and docetaxel in patients with previously treated non-small cell lung cancer: An Alpe–Adria Thoracic Oncology Multidisciplinary group trial (ATOM 019). European Journal of Cancer. 47(11). 1653–1659. 4 indexed citations

11.

Grossi, Francesco, Riccardo Spizzo, Domenico Bordo, et al.. (2010). Prognostic Stratification of Stage IIIA pN2 Non-small Cell Lung Cancer by Hierarchical Clustering Analysis of Tissue Microarray Immunostaining Data: An Alpe Adria Thoracic Oncology Multidisciplinary Group Study (ATOM 014). Journal of Thoracic Oncology. 5(9). 1354–1360. 23 indexed citations

12.

Rijavec, Erika, Ornella Belvedere, Marianna Aita, et al.. (2010). Docetaxel (D) versus docetaxel/gemcitabine (D&G) in the treatment of older patients with advanced non-small cell lung cancer (NSCLC): An Alpe Adria Thoracic Oncology Multidisciplinary Group randomized phase II trial (ATOM 017).. Journal of Clinical Oncology. 28(15_suppl). e18028–e18028. 5 indexed citations

13.

Grossi, Francesco, Gianpiero Fasola, C. Rossetto, et al.. (2006). Phase II study of irinotecan and docetaxel in patients with previously treated non-small cell lung cancer: An Alpe-Adria Thoracic Oncology Multidisciplinary group study (ATOM 007). Lung Cancer. 52(1). 89–92. 9 indexed citations

14.

Belvedere, Ornella, Chiara Sacco, Andrea Ardizzoni, et al.. (2006). Second line chemotherapy with topotecan and gemcitabine in small cell lung cancer (SCLC) patients: An Alpe-Adria Thoracic Oncology Multidisciplinary group phase II study (ATOM 012). Journal of Clinical Oncology. 24(18_suppl). 17014–17014. 1 indexed citations

15.

Grossi, Francesco, Ornella Belvedere, C. Rossetto, et al.. (2004). Irinotecan plus docetaxel in previously treated non-small cell lung cancer (NSCLC): An Alpe Adria Thoracic Oncology Multidisciplinary group phase II study (ATOM 007). Journal of Clinical Oncology. 22(14_suppl). 7363–7363. 3 indexed citations

16.

Belvedere, Ornella, Francesca Valent, C. Rossetto, et al.. (2003). P-183 Post-operative thoracic radiation therapy (TRT) in radically resected, chemonaive IIIA N2 non-small cell lung cancer (NSCLC) patients: an Alpe Adria Thoracic Oncology Multidisciplinary group study (ATOM 010). Lung Cancer. 41. S136–S137.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact